Apogee Therapeutics News

Apogee Therapeutics | 8-K: Current report

Oct 24 20:13

Apogee Therapeutics | 8-K: Current report

Aug 19 19:32

Apogee Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Aug 13 05:31

Apogee Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 13 04:06

Apogee Therapeutics | 8-K: Current report

Jun 8 04:10

Apogee Therapeutics | DEFA14A: Others

May 28 19:41

Apogee Therapeutics | 8-K: Current report

May 28 19:36

Apogee Therapeutics | 8-K: Current report

May 16 04:49

Apogee Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 13 19:29

Apogee Therapeutics | DEF 14A: Definitive information statements

Apr 25 04:21

Apogee Therapeutics | DEFA14A: Others

Apr 25 04:20

Apogee Therapeutics | 8-K: Current report

Mar 25 19:33

Apogee Therapeutics | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1

Mar 8 07:31

Apogee Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Mar 6 05:09

Apogee Therapeutics | 8-K: Current report

Mar 5 21:17

Apogee Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 28, 2023 20:38

Apogee Therapeutics | 8-K: Current report

Aug 21, 2023 19:35

Apogee Therapeutics | 8-K: Current report

Aug 7, 2023 19:35

Apogee Therapeutics | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1

Jul 14, 2023 05:00

Apogee Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 10, 2023 18:01